Old Web
English
Sign In
Acemap
>
authorDetail
>
M Lopez-Bresnahan
M Lopez-Bresnahan
Medicine
Interferon beta-1a
Multiple sclerosis
Pathology
Clinical trial
4
Papers
187
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The design of the CLARITY study (CLAdRIbine tablets Treating multiple sclerosis orallY)
2006
Gavin Giovannoni
Stuart D. Cook
Peter Rieckmann
P. Vermersch
P Soelberg-Sorensen
G. Comi
P Chang
M Lopez-Bresnahan
R. Kim
Show All
Source
Cite
Save
Citations (0)
A randomized, multicentre, open-label, parallel-group trial of the tolerability of interferon beta-1a (Rebif®) administered by autoinjection or manual injection in relapsing-remitting multiple sclerosis
2005
Multiple Sclerosis Journal
D Mikol
M Lopez-Bresnahan
S Taraskiewicz
P Chang
J Rangnow
Show All
Source
Cite
Save
Citations (56)
Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis
2005
Neurology
M. Sandberg-Wollheim
D. Frank
T. M. Goodwin
B. Giesser
M Lopez-Bresnahan
M. Stam Moraga
P Chang
G.S. Francis
Show All
Source
Cite
Save
Citations (130)
EXACERBATION OR UNMASKING OF FOCAL NEUROLOGIC DEFICITS BY SEDATIVE MEDICATION
1993
Journal of Neurosurgical Anesthesiology
G. Thal
Michele D. Szabo
M Lopez-Bresnahan
Gregory Crosby
Show All
Source
Cite
Save
Citations (1)
1